Return to Trial Database

HCRN-GI02-38

A Phase II Study of Capecitabine plus Docetaxel Combination in Patients with Esophageal/Gastric Cancer

Status

Study Completed

Cancer Type(s)

Study Contact

Trial Locations

All sites in which the trial HCRN-GI02-38 being conducted in.

No data was found